Physician

John Kenneth Baker, M.D.

According to 2025 Medicare claims, John Baker, M.D. (NPI: 1598922130) practices neurology in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is COLONIAL FAMILY PRACTICE, LLC (NPI: 1518074640; TIN: 02-0626080) and primary practice location at 29150-1987. Baker is affiliated with the CareMount Value Partners IPA (ACO ID: D0019), participating under the REACH model.

Baker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 927 traditional Medicare patients, billed 48,772 HCPCS/CPT codes, and received $464,710 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,805 prescription claims across 1,054 beneficiaries totaling $8,013,858 in drug costs, led by Firdapse (Amifampridine Phosphate). DME data shows 57 claims. Open Payments data shows 441 records totaling $128,549. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,734,357 to $8,013,858. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $24,673 and ending at $5,122.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,012	17,466	$430,801
2016	1,064	21,330	$471,541
2017	1,156	25,403	$489,085
2018	1,204	32,483	$537,734
2019	1,186	35,033	$558,116
2020	1,083	39,776	$481,488
2021	1,046	42,611	$496,319
2022	1,063	44,785	$471,215
2023	1,048	50,649	$490,510
2024	927	48,772	$464,710

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	497	4,761	$2,734,357
2016	540	5,574	$2,836,260
2017	591	5,402	$3,162,815
2018	613	5,723	$3,293,637
2019	705	6,016	$3,719,903
2020	767	6,138	$5,215,287
2021	907	6,079	$7,396,201
2022	964	6,108	$8,081,069
2023	1,063	7,286	$8,535,962
2024	1,054	6,805	$8,013,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	21	75	$5,995
2016	23	39	$2,189
2017	22	35	$2,768
2018	51	87	$13,448
2019	33	170	$62,863
2020	27	192	$7,138
2021	26	165	$5,570
2022	69	174	$6,538
2023	24	111	$3,974
2024	N/R	57	$150,448

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	337	499	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	578	881	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	747	1,344	$11
36415	Insertion of needle into vein for collection of blood sample	241	288	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	169	188	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Firdapse	Amifampridine Phosphate	44	1,298	$1,262,322
Austedo Xr	Deutetrabenazine	94	2,820	$688,406
Ingrezza	Valbenazine Tosylate	77	2,310	$612,078
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	22	616	$458,515
Gammaked	Immune Globul G/Gly/Iga Avg 46	30	686	$405,361

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	14	$149,117
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	14	$1,016
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	16	$181
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	441	$128,549	Neurocrine Biosciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Kenneth Baker, M.D.?

Tedicare shows public-source Medicare data for John Kenneth Baker, M.D. (NPI 1598922130), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Kenneth Baker, M.D. have ACO affiliation data?

John Kenneth Baker, M.D. is shown with ACO affiliation data for CareMount Value Partners IPA (REACH, ACO ID D0019).

What billing organization is linked to John Kenneth Baker, M.D.?

John Kenneth Baker, M.D. is linked to COLONIAL FAMILY PRACTICE, LLC (billing NPI 1518074640) in the available physician profile data.

Does John Kenneth Baker, M.D. have Open Payments data?

John Kenneth Baker, M.D. has 441 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.